Ordering
Available Variants0.5 mg
CHA.67975-0.5mg
Price
€46.56
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
0.5 mg | CHA.67975-0.5mg | €46.56 |
Hybri-Max™, γ-irradiated, 50x, lyophilized powder, BioXtra, suitable for hybridoma
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C5H7N3O4 |
|---|---|
| CAS Number | 115-02-6 |
| Molecular Weight | 173.13 |
| UNSPSC Code | 12352207 |
| NACRES | NA.75 |
| PubChem Substance ID | 24890511 |
| EC Number | 204-061-6 |
| Beilstein/REAXYS Number | 1726602 |
| MDL number | MFCD00036802 |
Safety Information Handling visibility
| pictograms |
GHS06
GHS08
  GHS06,GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H301,H351 |
| pcodes | P201 - P301 + P310 + P330 |
| Hazard Classifications | Acute Tox. 3 Oral - Carc. 2 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Azaserine, with the chemical formula C4H7N5O3 and CAS number 115-02-6, is a naturally occurring antibiotic and antineoplastic agent. It is produced by the bacterium Streptomyces fragilis and has been shown to exhibit inhibitory effects on various microorganisms and cancer cells. Azaserine acts as a glutamine analog, interfering with the biosynthesis of nucleic acids and proteins, thereby inhibiting cell growth and proliferation. Its mechanism of action involves the inhibition of glutaminase and other enzymes involved in amino acid metabolism, leading to the depletion of essential nutrients required for cell survival. As a result, azaserine has been investigated for its potential therapeutic applications in the treatment of cancer and other diseases characterized by abnormal cell growth and proliferation. Further research is needed to fully explore its clinical potential and optimize its therapeutic use.
